This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shirai, T. Search for Related Content PubMed PubMed Citation Articles by Shirai, T. Social Bookmarking                         What's this?

Review Article: A Medium-Term Rat Liver Bioassay as a Rapid In Vivo Test for Carcinogenic Potential: A Historical Review of Model Development and Summary of Results from 291 Tests

Department of Pathology, Nagoya City University Medical School, Nagoya 467, Japan

A bioassay system for rapid detection of carcinogenic agents has been developed using male Fischer 344 rats to bridge the gap between long-term carcinogenicity tests and short-term screening assays. The system, called the medium-term liver bioassay, is fundamentally based on the 2-stage hypothesis of tumor production, employing initiation by diethylnitrosamine (200 mg/kg, ip) in the first stage and test chemical administration during the second, in combination with two-thirds partial hepatectomy. It requires only 8 wk for animal experimentation and a further few weeks for quantitative analysis of immunohistochemically demonstrated glutathione S-transferase placental form positive hepatic foci. A total of 291 chemicals/substances have already been analyzed in our laboratory. Among 63 chemicals that were proved to be carcinogenic in the liver of rat and/or mouse, 57 (90%) gave positive results irrespective of their mutagenicity. Negative compounds include peroxisome proliferators and tamoxifen. Even nonhepatocarcinogens were positive at a rate of 24%. Eighty-six percent (12/14) of mouse liver carcinogens were also positive. On the other hand, only 2 out of 45 noncarcinogens showed very weak positivity. Thus, the efficacy of the system for hepatocarcinogens has been well established. This bioassay is increasingly regarded as an appropriate alternative test for carcinogenicity risk assessment and is practically used for a rapid evaluation of hepatocarcinogenicity of chemicals.

Key Words: Hepatocarcinogen • glutathione S-transferase placental form (GST-P)-positive foci • risk assessment • rat

Toxicologic Pathology, Vol. 25, No. 5, 453-460 (1997)
DOI: 10.1177/019262339702500504


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Takahashi, M. Shibutani, G.-H. Woo, K. Inoue, H. Fujimoto, K. Igarashi, J. Kanno, M. Hirose, and A. Nishikawa Cellular distributions of molecules with altered expression specific to the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model Carcinogenesis, November 1, 2008; 29(11): 2218 - 2226. [Abstract] [Full Text] [PDF]

				M. Lohitnavy, Y. Lu, O. Lohitnavy, L. S. Chubb, S. Hirono, and R. S. H. Yang A Possible Role of Multidrug Resistance-Associated Protein 2 (Mrp2) in Hepatic Excretion of PCB126, an Environmental Contaminant: PBPK/PD Modeling Toxicol. Sci., July 1, 2008; 104(1): 27 - 39. [Abstract] [Full Text] [PDF]

				J. F. Brown Jr, B. A. Mayes, J. B. Silkworth, and S. B. Hamilton Polychlorinated Biphenyls Modulated Tumorigenesis in Sprague Dawley Rats: Correlation with Mixed Function Oxidase Activities and Superoxide (O2* ) Formation Potentials and Implied Mode of Action Toxicol. Sci., August 1, 2007; 98(2): 375 - 394. [Abstract] [Full Text] [PDF]

				H. Tsuda, S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Wakabayashi, and M. A. Moore Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work Toxicol Pathol, January 1, 2003; 31(1): 80 - 86. [Abstract] [PDF]

				C. Uneyama, M. Shibutani, N. Masutomi, H. Takagi, and M. Hirose Methacarn Fixation for Genomic DNA Analysis in Microdissected, Paraffin-embedded Tissue Specimens J. Histochem. Cytochem., September 1, 2002; 50(9): 1237 - 1245. [Abstract] [Full Text] [PDF]

				M. Shibutani, N. Takahashi, T. Kobayashi, C. Uneyama, N. Masutomi, A. Nishikawa, and M. Hirose Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay Carcinogenesis, June 1, 2002; 23(6): 1047 - 1055. [Abstract] [Full Text] [PDF]

				K. Imaida, K. Kuzutani, J. Wang, O. Fujiwara, T. Ogiso, K. Kato, and T. Shirai Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields Carcinogenesis, November 1, 2001; 22(11): 1837 - 1841. [Abstract] [Full Text] [PDF]